Evidence map›Paper›PMID 21734051›Full record

ArticleJournal of virology2011

Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.

Amélie Fradet-Turcotte, Fanny Bergeron-Labrecque, Cary A Moody, Michaël Lehoux, Laimonis A Laimins, Jacques Archambault

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 138 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Role of HPV16 E1 in cervical carcinogenesis.Frontiers in cellular and infection microbiology · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Amélie Fradet-TurcotteLaboratory of Molecular Virology, Institut de Recherches Cliniques de Montréal, 110 Pine Avenue West, Montreal, Quebec, Canada H2W 1R7.
Fanny Bergeron-Labrecque
Cary A Moody
Michaël Lehoux
Laimonis A Laimins
Jacques Archambault
Montreal Clinical Research Institute · CANorthwestern University · USUNC Lineberger Comprehensive Cancer Center

Funding

The Role of Caspase Activation in the Differentiation-Dependent Life Cycle of HPVR00CA137160 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MOODY, CARY A · 2010 to 2012
$732k
CIHR 89841-1NCI NIH HHS R00 CA137160
6 · The paper itself

Abstract

Replication of the papillomavirus genome is initiated by the assembly of a complex between the viral E1 and E2 proteins at the origin. The E1 helicase is comprised of a C-terminal ATPase/helicase domain, a central domain that binds to the origin, and an N-terminal regulatory region that contains nuclear import and export signals mediating its nucleocytoplasmic shuttling. We previously reported that nuclear accumulation of E1 has a deleterious effect on cellular proliferation which can be prevented by its nuclear export. Here we have shown that nuclear accumulation of E1 from different papillomavirus types blocks cell cycle progression in early S phase and triggers the activation of a DNA damage response (DDR) and of the ATM pathway in a manner that requires both the origin-binding and ATPase activities of E1. Complex formation with E2 reduces the ability of E1 to induce a DDR but does not prevent cell cycle arrest. Transient viral DNA replication still occurs in S-phase-arrested cells but surprisingly is neither affected by nor dependent on induction of a DDR and of the ATM kinase. Finally, we provide evidence that a DDR is also induced in human papillomavirus type 31 (HPV31)-immortalized keratinocytes expressing a mutant E1 protein defective for nuclear export. We propose that nuclear export of E1 prevents cell cycle arrest and the induction of a DDR during the episomal maintenance phase of the viral life cycle and that complex formation with E2 further safeguards undifferentiated cells from undergoing a DDR when E1 is in the nucleus.

Indexed as

Cell CycleDNA RepairHost-Pathogen InteractionsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineDNA-Binding ProteinsDNA HelicasesHumansOncogene Proteins, ViralPapillomaviridaeProtein Serine-Threonine KinasesTumor Suppressor ProteinsVirus ReplicationAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsDNA HelicasesOncogene Proteins, ViralProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID21734051
PMCPMC3165840
OpenAlexW2075755751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.